Turning insight into action for a haemophilia brand launch

Launching a new brand for haemophilia means changing the habits of a small, specialised community of treaters who have managed their patients on familiar protocols for years. The client had invested heavily in data and insight, but it was fragmented across studies and teams and not shaping decision-making. With a launch ahead in a market where slow adoption could quickly become entrenched, they needed a way to turn insight into clear, timely action.

We built custom AI agents, including HCP personas and subject matter experts such as behavioural scientists, trained on the client’s brand strategy and past insights. This allowed teams to interrogate the data themselves – they could test ideas and challenge their assumptions, turning static insight into a working tool for everyday decisions.

Heading into launch, the team had a clear, real-time view of how the market was likely to respond. They could spot barriers early and refine their approach. The first patient was treated within a week of product availability.